The Dog Aging Project has reached an exciting milestone in its landmark dog aging study on healthy aging in dogs. The project recently announced that the first participants—Zoe and Jack—have completed their full three-year involvement in the Test of Rapamycin in Aging Dogs (TRIAD), a groundbreaking clinical trial exploring whether rapamycin for dogs can slow…

Early results from a phase 1 clinical trial suggest that weekly administration of rapamycin may significantly improve patient-reported outcome measures (PROMs) in individuals living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This emerging rapamycin ME/CFS trial adds to growing evidence around low-dose rapamycin for ME/CFS patients and highlights increasing interest in rapamycin as a potential option…

A medication once reserved for preventing organ rejection, rapamycin is now gaining momentum in the field of longevity and rapamycin for anti-aging research. Initially created as an immunosuppressive drug, rapamycin is now being studied for its potential to slow aging and support rapamycin lifespan extension in humans. With growing scientific support pointing to its possible…

1. mTOR Pathway and Aging The mTOR pathway controls cell growth, protein synthesis, and metabolism and plays a critical role in muscle health. As we age, overactive mTOR signaling contributes to problems like muscle wasting (sarcopenia), chronic inflammation, and mitochondrial decline—key challenges associated with rapamycin for aging muscles. This process aligns with broader insights into…

What Is Rapamycin? Rapamycin is a drug that was originally used to prevent organ transplant rejection. It works by inhibiting a protein complex called mTOR (mechanistic Target of Rapamycin), which plays a major role in cell growth, aging, and metabolism. This core mechanism is widely discussed in rapamycin and mTOR as the hidden switch controlling…

In this article, The New York Times provides real-world examples of how rapamycin works in humans. The report explores the idea of a rapamycin anti-aging pill, drawing on the words and perspectives of doctors, researchers, and users themselves. This discussion closely mirrors broader analyses such as can rapamycin really help you live longer? and the…

What Is Rapamycin Off-Label Use? Rapamycin off-label use refers to the practice of prescribing this medication for purposes beyond what it was originally approved for by regulatory authorities like the FDA. While off-label use is both legal and common, it typically occurs when a physician believes the drug may provide benefits for a specific condition…

Rapamycin has several important uses in human medicine, highlighting a wide range of Rapamycin benefits, particularly in transplant medicine and other clinical and research areas. Here’s how sirolimus can help people, as also discussed in broader overviews of rapamycin and longevity science and its expanding medical role. 1. Prevention of Organ Rejection (Immunosuppressive Therapy) One…

Rapamycin has gained attention as a potential life-extending drug in humans, and there’s growing interest in rapamycin for pets, particularly dogs. Rapamycin is an immunosuppressant that has been used for various medical conditions, including preventing organ transplant rejection and treating certain cancers. More recently, scientists have begun exploring its potential role in rapamycin pet longevity,…

Dr. Mikhail Blagosklonny is best known for his pioneering research on aging, cancer, and the Rapamycin mTOR pathway, which is central to his work on rapamycin and its potential as an anti-aging and cancer therapeutic. He has written extensively about the potential of rapamycin for anti aging. His research largely focuses on the mTOR pathway,…